These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9121488)

  • 1. Induction of a novel conformation in the progesterone receptor by ZK299 involves a defined region of the carboxyl-terminal tail.
    Allan GF; Lombardi E; Haynes-Johnson D; Palmer S; Kiddoe M; Kraft P; Campen C; Rybczynski P; Combs DW; Phillips A
    Mol Endocrinol; 1996 Oct; 10(10):1206-13. PubMed ID: 9121488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
    Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
    Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
    Leonhardt SA; Altmann M; Edwards DP
    Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onapristone (ZK299) and mifepristone (RU486) regulate the messenger RNA and protein expression levels of the progesterone receptor isoforms A and B in the bovine endometrium.
    Rekawiecki R; Kowalik MK; Kotwica J
    Theriogenology; 2015 Aug; 84(3):348-57. PubMed ID: 25976976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.
    Wardell SE; Narayanan R; Weigel NL; Edwards DP
    Mol Endocrinol; 2010 Feb; 24(2):335-45. PubMed ID: 20008003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity.
    Wei LL; Hawkins P; Baker C; Norris B; Sheridan PL; Quinn PG
    Mol Endocrinol; 1996 Nov; 10(11):1379-87. PubMed ID: 8923464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor.
    Vegeto E; Allan GF; Schrader WT; Tsai MJ; McDonnell DP; O'Malley BW
    Cell; 1992 May; 69(4):703-13. PubMed ID: 1586949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody.
    Weigel NL; Beck CA; Estes PA; Prendergast P; Altmann M; Christensen K; Edwards DP
    Mol Endocrinol; 1992 Oct; 6(10):1585-97. PubMed ID: 1448113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist and antagonist-induced qualitative and quantitative alterations of progesterone receptor from breast cancer cells.
    Hurd C; Nag K; Khattree N; Alban P; Dinda S; Moudgil VK
    Mol Cell Biochem; 1999 Sep; 199(1-2):49-56. PubMed ID: 10544951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues.
    Lin VC; Aw SE; Ng EH; Ng EH; Tan MG
    Br J Cancer; 2001 Dec; 85(12):1978-86. PubMed ID: 11747343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of ligand binding, DNA binding and phosphorylation of progesterone receptor by two novel progesterone receptor antagonist ligands.
    Hurd C; Underwood B; Herman M; Iwasaki K; Kloosterboer HJ; Dinda S; Moudgil VK
    Mol Cell Biochem; 1997 Oct; 175(1-2):205-12. PubMed ID: 9350053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.
    Sartorius CA; Tung L; Takimoto GS; Horwitz KB
    J Biol Chem; 1993 May; 268(13):9262-6. PubMed ID: 8387487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor.
    DeMarzo AM; Oñate SA; Nordeen SK; Edwards DP
    Biochemistry; 1992 Nov; 31(43):10491-501. PubMed ID: 1420166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionic and ligand-specific effects on the DNA binding of progesterone receptor bound to the synthetic progestin R5020 and the antiprogestin RU486.
    Chao CC; Thomas TJ; Ebede P; Gallo MA; Thomas T
    Cancer Res; 1991 Aug; 51(15):3938-45. PubMed ID: 1855211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atomic structure of progesterone complexed with its receptor.
    Williams SP; Sigler PB
    Nature; 1998 May; 393(6683):392-6. PubMed ID: 9620806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone receptor and the mechanism of action of progesterone antagonists.
    Edwards DP; Altmann M; DeMarzo A; Zhang Y; Weigel NL; Beck CA
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):449-58. PubMed ID: 7626494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
    Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
    Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The X-ray structure of RU486 bound to the progesterone receptor in a destabilized agonistic conformation.
    Raaijmakers HC; Versteegh JE; Uitdehaag JC
    J Biol Chem; 2009 Jul; 284(29):19572-9. PubMed ID: 19372222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor.
    Xu J; Nawaz Z; Tsai SY; Tsai MJ; O'Malley BW
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12195-9. PubMed ID: 8901556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of human progesterone receptor A and B form-mediated trans-activation by phosphorylation.
    Kazmi SM; Visconti V; Plante RK; Ishaque A; Lau C
    Endocrinology; 1993 Sep; 133(3):1230-8. PubMed ID: 8365365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.